Synoste
Synoste has developed an implantable medical device for limb lengthening. Bio-compatible shape memory alloys combined with wireless energy transfer of the homecare device are used to achieve the bone lengthening desired by the patient and the surgeon.
Status:
Startup company
SDGs:
Good health and well-being
Industry:
Life science and medical
Impact:
Quality of life
Origin:
School of Science
Established:
2012
Looking for:
Collaboration, Funding
Synoste was acquired by Globus Medical.
Limb-lengthening implant developer Synoste raises several million in funding
The Aalto University spin-out company will use the funds to commercialise its painless limb-lengthening method.
- Published:
- Updated: